TickerFactsScreenerDevelopers

Apimeds Pharmaceuticals US, Inc. (APUS) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2022: -$713.6K2023: $31.9K2024: -$1.36M2025: $153.35M$153.35M
2022Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$153.35M+11391.2%
2024-$1.36M-4361.6%
2023$31.9K+104.5%
2022-$713.6K—